MBXBF (Microbix Biosystems) Payments of Debt: $-0.32 Mil (TTM As of Mar. 2026)


MBXBF Microbix Biosystems Inc MBXBF
51 GF Score
Price $0.22
GF Value $0.18
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems Payments of Debt?

Microbix Biosystems MBXBF 51 Payments of Debt is $-0.32 Mil as of Mar. 2026. GuruFocus rates MBXBF with a GF Score™ of 51/100 and a GF Value™ of $0.18 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Microbix Biosystems's Payments of Debt for the three months ended in Mar. 2026 was $-0.18 Mil.

Microbix Biosystems's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.32 Mil.

Microbix Biosystems Payments of Debt Related Terms

Microbix Biosystems Payments of Debt Historical Data

* Premium members only.

The historical data trend for Microbix Biosystems's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems Payments of Debt Chart

Microbix Biosystems Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.43 -1.84 -0.22 -0.39 -1.03

Microbix Biosystems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.41 -0.04 -0.05 -0.05 -0.18
MBXBF
51GF Score
Microbix Biosystems Inc MBXBF
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbix Biosystems Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-0.32 Mil mean?
Microbix Biosystems (MBXBF) has a Payments of Debt of $-0.32 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Microbix Biosystems and its competitors.
Is Microbix Biosystems' Payments of Debt too high?
Microbix Biosystems' current Payments of Debt is $-0.32 Mil. Overall, Microbix Biosystems has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' Payments of Debt compare to VRTX and REGN?
Microbix Biosystems' Payments of Debt of $-0.32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Microbix Biosystems and its competitors. Microbix Biosystems's current Payments of Debt is $-0.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.18, compared to a current price of $0.22 — trading 19.4% above its estimated fair value. The current Payments of Debt is $-0.32 Mil. Microbix Biosystems' overall GF Score™ is 51/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Payments of Debt is $-0.32 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.22 is trading 19.4% above its estimated GF Value™ of $0.18. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for MBXBF:

  • Payments of Debt: $-0.32 Mil
  • GF Value™: $0.18 vs. price of $0.22 (19.4% above fair value)
  • GF Score™: 51/100 with 8 warning signs

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbix Biosystems Business Description

Other Exchanges MBX:Canada
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
51GF Score

Get the complete analysis for MBXBF

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$0.18
GF Value